Colon Cancer - UPDATE:Roche’s Avastin Fails In Early Colon Cancer, Dims Hope - CNN Money
UPDATE:Roche’s Avastin Fails In Early Colon Cancer, Dims Hope - CNN Money
ORLANDO -(Dow Jones)- The details of a failed study involving Roche Holding AG’s (RHHBY) Avastin showed the drug’s effectiveness in preventing early-stage colon cancer diminished when patients stopped taking it, a disappointing result. The data
Colon Cancer Treatment Cost Concern For Patients - HULIQ.com
The vast majority of advanced colon cancer patients in a clinical trial were not concerned about the cost of prescription drugs for managing chemotherapy side effects, such as infection, pain and nausea and few adopted strategies to reduce drug cost
Avastin’s Failure to Extend Cancer Survival Is Detailed - CNBC
A study of blockbuster drug Avastin in colon cancer patients who have undergone surgery showed that the drug’s effectiveness wore off after patients stopped taking it, researchers said Saturday. As previously disclosed by the drug’s maker, Roche
Poniard reports positive cancer study data - Boston Globe
SOUTH SAN FRANCISCO, Calif. Poniard Pharmaceuticals Inc. said Thursday its colon and prostate cancer drug candidate met key treatment and safety goals in midstage studies. The South San Francisco-based company said updated study results for a